SEC Comment Letter for Evolus, Inc. (EOLS) (CIK 0001570562) (EOLS) — Jul 11, 2018
Evolus, Inc. (EOLS) (CIK 0001570562)
Date: July 11, 2018 · CIK: 0001570562 · Accession: 0000000000-18-021245
AI Filing Summary & Sentiment
Show Raw Text
July 11, 2018
David Moatazedi
President and Chief Executive Officer
Evolus, Inc.
17901 Von Karman Avenue, Suite 150
Irvine, CA 92614
Re:Evolus, Inc.
Draft Registration Statement on Form S-1
Submitted July 2, 2018
CIK No. 0001570562
Dear Mr. Moatazedi:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Michael A. Hedge, Esq.